Yossi Ben Amram
Directeur/Membre du Conseil chez POLYPID LTD.
Profil
Yossi Ben Amram is the founder of MediCane Health, Inc. (founded in 2019) where he holds the title of Chairman & Co-Chief Executive Officer.
He is currently working as an Independent Director at PolyPid Ltd., President at Quris Technologies Ltd., and Chief Strategy Officer at Golden Age Health Pte Ltd.
Mr. Amram has an educational background with an undergraduate degree and an MBA from The Leon Recanati Graduate School of Business Administration.
Postes actifs de Yossi Ben Amram
| Sociétés | Poste | Début |
|---|---|---|
| POLYPID LTD. | Directeur/Membre du Conseil | 01/05/2023 |
MediCane Health, Inc.
 MediCane Health, Inc. Food: Major DiversifiedConsumer Non-Durables MediCane Health, Inc. is an Israeli international pharmaceutical company that specializes in the research, development, production, and marketing of cannabis-based medications. The company is based in Kfar Saba, Israel. Its subsidiaries, M.H MediCane Ltd. and MediCane R&D Ltd., develop medical cannabis and pharmaceutical products derived from synthetic and isolated cannabis molecules in three therapeutic areas: dementia, insomnia, and irritable bowel syndrome. The company's R&D activities are carried out in-house by its experienced team and through collaboration with world-renowned scientists and leading research institutions. MediCane Health has operational subsidiaries in various countries and a commercial hub. The company was founded by Yossi Ben Amram and Hagai Greenspoon, and Yossi Ben Amram has been the CEO since incorporation. | Directeur Général | 01/03/2019 |
Quris Technologies Ltd.
 Quris Technologies Ltd. Packaged SoftwareTechnology Services Quris Technologies Ltd. is a company based in Tel Aviv, Israel that is revolutionizing the drug development process by pioneering clinical trials on chips. The Israeli company tests thousands of novel drug candidates on hundreds of miniaturized "patients-on-a-chip" using their fully automated, self-training AI platform. This platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively than ever before, all while minimizing animal testing. The company was founded by Isaac Bentwich and Yossi Haran, and Isaac Bentwich has been the CEO since incorporation. | President | 01/06/2023 |
Formation de Yossi Ben Amram
| The Leon Recanati Graduate School of Business Administration | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| POLYPID LTD. | Health Technology |
| Entreprise privées | 2 |
|---|---|
MediCane Health, Inc.
MediCane Health, Inc. Food: Major DiversifiedConsumer Non-Durables MediCane Health, Inc. is an Israeli international pharmaceutical company that specializes in the research, development, production, and marketing of cannabis-based medications. The company is based in Kfar Saba, Israel. Its subsidiaries, M.H MediCane Ltd. and MediCane R&D Ltd., develop medical cannabis and pharmaceutical products derived from synthetic and isolated cannabis molecules in three therapeutic areas: dementia, insomnia, and irritable bowel syndrome. The company's R&D activities are carried out in-house by its experienced team and through collaboration with world-renowned scientists and leading research institutions. MediCane Health has operational subsidiaries in various countries and a commercial hub. The company was founded by Yossi Ben Amram and Hagai Greenspoon, and Yossi Ben Amram has been the CEO since incorporation. | Consumer Non-Durables |
Quris Technologies Ltd.
Quris Technologies Ltd. Packaged SoftwareTechnology Services Quris Technologies Ltd. is a company based in Tel Aviv, Israel that is revolutionizing the drug development process by pioneering clinical trials on chips. The Israeli company tests thousands of novel drug candidates on hundreds of miniaturized "patients-on-a-chip" using their fully automated, self-training AI platform. This platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively than ever before, all while minimizing animal testing. The company was founded by Isaac Bentwich and Yossi Haran, and Isaac Bentwich has been the CEO since incorporation. | Technology Services |
